| SAMVX | VMVAX | SAMVX / VMVAX | |
| Total Expense Ratio | 1.31 | 0.07 | 1,871% |
| Annual Report Gross Expense Ratio | 1.31 | 0.07 | 1,871% |
| Fund Existence | 23 years | 15 years | - |
| Gain YTD | 17.695 | 12.951 | 137% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.28B | 36.6B | 3% |
| Annual Yield % from dividends | 0.84 | 1.88 | 45% |
| Returns for 1 year | 16.79 | 19.99 | 84% |
| Returns for 3 years | 28.59 | 44.66 | 64% |
| Returns for 5 years | -3.25 | 42.73 | -8% |
| Returns for 10 years | 17.52 | 128.29 | 14% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HMSFX | 13.00 | 0.15 | +1.17% |
| Hennessy Midstream Investor | |||
| PDIFX | 17.79 | 0.10 | +0.57% |
| Principal Diversified International R6 | |||
| COFYX | 43.64 | 0.16 | +0.37% |
| Columbia Contrarian Core Inst3 | |||
| MGORX | 37.50 | -0.43 | -1.13% |
| Morgan Stanley Inst Global Opp IR | |||
| EMRIX | 21.72 | -0.46 | -2.07% |
| VanEck Emerging Markets I | |||